Omgiri Goswami ایک نیا مضمون بنایا
6 میں

β-Nicotinamide Mononucleotide (NMN) to Reach USD 913.45 Million by 2032, Driven by Increasing Consumer Awareness of Anti-Aging Benefits and Advancements in Biotechnological Manufacturing | #research

β-Nicotinamide Mononucleotide (NMN) to Reach USD 913.45 Million by 2032, Driven by Increasing Consumer Awareness of Anti

β-Nicotinamide Mononucleotide (NMN) to Reach USD 913.45 Million by 2032, Driven by Increasing Consumer Awareness of Anti

β-Nicotinamide Mononucleotide (NMN) market valued at USD 432 Million in 2025, is projected to reach USD 913.45 Million by 2032, growing at CAGR of 10.90%.